Ionis Pharmaceuticals
IONS
IONS
329 hedge funds and large institutions have $6.36B invested in Ionis Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 90 increasing their positions, 116 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.71% less ownership
Funds ownership: 86.3% → 85.59% (-0.71%)
22% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 116
43% less call options, than puts
Call options by funds: $64.2M | Put options by funds: $112M
Holders
329
Holding in Top 10
9
Calls
$64.2M
Puts
$112M
Top Buyers
| 1 | +$39.9M | |
| 2 | +$35.3M | |
| 3 | +$25.8M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$22.4M |
| 5 |
Two Sigma Advisers
New York
|
+$16.1M |
Top Sellers
| 1 | -$90.2M | |
| 2 | -$27.6M | |
| 3 | -$25.9M | |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$25.4M |
| 5 |
Goldman Sachs
New York
|
-$22.1M |